Transcriptional regulation of heme oxygenase-1 gene expression by MAP kinases of the JNK and p38 pathways in primary cultures of rat hepatocytes

J Biol Chem. 2003 May 16;278(20):17927-36. doi: 10.1074/jbc.M203929200. Epub 2003 Mar 11.

Abstract

Heme oxygenase-1 (HO-1) gene expression is induced by various oxidative stress stimuli including sodium arsenite. Since mitogen-activated protein kinases (MAPKs) are involved in stress signaling we investigated the role of arsenite and MAPKs for HO-1 gene regulation in primary rat hepatocytes. The Jun N-terminal kinase (JNK) inhibitor SP600125 decreased sodium arsenite-mediated induction of HO-1 mRNA expression. HO-1 protein and luciferase activity of reporter gene constructs with -754 bp of the HO-1 promoter were induced by overexpression of kinases of the JNK pathway and MKK3. By contrast, overexpression of Raf-1 and ERK2 did not affect expression whereas overexpression of p38alpha, beta, and delta decreased and p38gamma increased HO-1 expression. Electrophoretic mobility shift assays (EMSA) revealed that a CRE/AP-1 element (-668/-654) bound c-Jun, a target of the JNK pathway. Deletion or mutation of the CRE/AP-1 obliterated the JNK- and c-Jun-dependent up-regulation of luciferase activity. EMSA also showed that an E-box (-47/-42) was bound by a putative p38 target c-Max. Mutation of the E-box strongly reduced MKK3, p38 isoform-, and c-Max-dependent effects on luciferase activity. Thus, the HO-1 CRE/AP-1 element mediates HO-1 gene induction via activation of JNK/c-Jun whereas p38 isoforms act through a different mechanism via the E-box.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthracenes / pharmacology
  • Arsenites / pharmacology
  • Base Sequence
  • Cell Nucleus / metabolism
  • Cells, Cultured
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation, Enzymologic*
  • Heme Oxygenase (Decyclizing) / biosynthesis*
  • Heme Oxygenase (Decyclizing) / genetics*
  • Heme Oxygenase-1
  • Hepatocytes / enzymology*
  • JNK Mitogen-Activated Protein Kinases*
  • Luciferases / metabolism
  • MAP Kinase Kinase 4
  • Male
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase Kinases / metabolism*
  • Mitogen-Activated Protein Kinases / metabolism*
  • Models, Genetic
  • Molecular Sequence Data
  • Mutation
  • Plasmids / metabolism
  • Promoter Regions, Genetic
  • Protein Binding
  • Protein Isoforms
  • Protein Serine-Threonine Kinases / metabolism
  • Protein Structure, Tertiary
  • Proto-Oncogene Proteins c-raf / metabolism
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Sodium Compounds / pharmacology
  • Transcription, Genetic*
  • Transcriptional Activation
  • Transfection
  • Up-Regulation
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Anthracenes
  • Arsenites
  • Enzyme Inhibitors
  • Protein Isoforms
  • RNA, Messenger
  • Sodium Compounds
  • pyrazolanthrone
  • sodium arsenite
  • Luciferases
  • Heme Oxygenase (Decyclizing)
  • Heme Oxygenase-1
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-raf
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4
  • Mitogen-Activated Protein Kinase Kinases